WEDNESDAY, Oct. 4, 2023 (HealthDay News) — Recent research has suggested that viruses could play a role in the loss of pancreatic beta cells, which triggers type 1 diabetes. Now, a new trial finds antiviral medications, when given soon after a child is diagnosed with type 1 diabetes, might helpContinue Reading

MONDAY, Oct. 2, 2023 (HealthDay News) — Diabetes may accelerate the growth of a blood cancer known as multiple myeloma, affecting overall survival, according to a new study. The research, published Sept. 29 in the journal Blood Advances, also underscores differences in survival outcomes for Black patients versus white patientsContinue Reading

FRIDAY, Sept. 22, 2023 (HealthDay News) – New research suggests some newer diabetes treatments may not be as beneficial for Black patients, after earlier drug trials included small numbers of non-white people. Whether the medications — called sodium-glucose co-transporter 2 inhibitors (SGLT2-Is) and glucogen-like peptide 1 receptor agonists (GLP1-Ras) —Continue Reading

WEDNESDAY, Sept. 20, 2023 (HealthDay News) — Another diabetes drug maker is taking legal action against businesses in several states, alleging that they’re “fraudulently claiming” that their compounded products are the same as its medication. This time, it’s Eli Lilly suing certain medical spas, wellness centers and compounding pharmacies overContinue Reading